Clinical Trial: A Study to Evaluate Multicancer Detection (MCD) Tests and Their Impact on Participant Health and Cancer Screening, The Vanguard Study

U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06995898) titled 'A Study to Evaluate Multicancer Detection (MCD) Tests and Their Impact on Participant Health and Cancer Screening, The Vanguard Study' on May 29.

Brief Summary: This clinical trial studies the impact of two multicancer detection (MCD) tests, Shield and Avantect, as cancer screening tests in a population of adults aged 45-75 without cancer in underrepresented communities. This study provides early information on how well MCD tests perform as cancer screening tools and help researchers understand how patients and their doctors make decisions about their care when the MCD test comes back with a normal (negative) or an abnormal (positive...